“…As with earlier generations of quinoline anti-malarials, and consistent with product label warnings of encephalopathy, case reports of psychiatric effects from mefloquine typically describe a complex and diverse range of effects on mood, personality, thought, cognition, sleep, and behaviour [ 191 ]. These include asthenia [ 192 ], melancholia [ 193 ], anxiety [ 194 ], phobias [ 195 , 196 ], feelings of unrest [ 197 , 198 ], paranoia [ 199 ], increased self-esteem [ 200 , 201 ], impaired judgment [ 198 ], social disinhibition [ 192 , 202 ], giddiness [ 203 ], altered sexual libido [ 204 ], manic behaviour and paranoid delusions or psychosis [ 194 , 200 , 202 , 204 ], hyperreligiosity [ 204 ], depersonalization [ 192 , 198 , 205 ], concentration and cognitive problems [ 197 ], problems with word finding [ 201 ], disorientation [ 193 , 198 , 206 ], symptoms of amnesia and confusion or disorientation [ 192 , 193 , 203 ], sleep disorders [ 207 , 208 ], severe nightmares, [ 209 ] sleep paralysis and “flashbacks” [ 201 ], suicidal ideation [ 210 ], and suicide [ 176 , 211 – 213 ].…”